Nonhuman primate models for islet transplantation in type 1 diabetes research.
Insulin-dependent diabetes mellitus is an autoimmune disease that causes a progressive destruction of the pancreatic beta cells. As a result, the patient requires exogenous insulin to maintain normal blood glucose levels. Both the pancreas and the islets of Langerhans have been transplanted successfully in humans and in animal models, resulting in full normalization of glucose homeostasis. However, insulin independence, transient or persistent, was documented in only a small fraction of cases until recently. The chronic immunosuppression required to avoid immunological rejection appears to be toxic to the islets and adds the risk of lymphoproliferative disease reported earlier. For islet transplantation to become the method of choice, it is essential first to identify islet-friendly immunosuppressive regimens and/or to develop methods that induce donor-specific tolerance and improve islet isolation and transplantation protocols. Indeed, researchers have already successfully allografted islets in the presence of nonsteroidal immunosuppression in a process known as the Edmonton protocol. An alternative method, gene therapy, could replace these other methods and better meet the insulin requirement of an individual without requiring pancreatic or islet transplantation. This alternative, however, requires animal models to develop and test clinical protocols and to demonstrate the feasibility of preclinical trials. Nonhuman primates are ideally suited to achieve these goals. The efforts toward developing a nonhuman primate diabetic model with demonstrable insulin dependence are discussed and include pancreatic and islet transplant trials to reverse the diabetic state and achieve insulin independence. Also described are the various protocols that have been tested in primates to circumvent immunosuppression by using tolerance induction strategies in lieu of immunosuppression, thus exploring the field of donor-specific tolerance that extends beyond islet transplantation.
Gaur
Lakshmi K
LK
Washington National Primate Research Center, Department of Microbiology, University of Washington, School of Medicine, Seattle, WA, USA.
D000818:Animals; D003922:Diabetes Mellitus, Type 1 / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D004195:Disease Models, Animal; D000882:Haplorhini; D016381:Islets of Langerhans Transplantation; D008992:Monkey Diseases / Q000209:etiology / Q000473:pathology / Q000601:surgery*; D010180:Pancreatectomy; D013311:Streptozocin
D013311:Streptozocin